Results 71 to 80 of about 485 (159)

Mimosa ditans

open access: yes, 2019
Pollen from Brazilian Savannah (Cerrado), Mato Grosso do Sul state.
Ariadne Barbosa Gonçalves (788714)
core   +1 more source

Migraines: unraveling the mystery [PDF]

open access: yes
Migraine is a prevalent and complex neurological disorder that significantly impacts the quality of life of affected individuals. This paper explores the pathophysiology, classification, and treatment options for migraine.
Librić, Lukas
core   +1 more source

An explainable web application based on machine learning for predicting fragility fracture in people living with HIV: data from Beijing Ditan Hospital, China

open access: yesFrontiers in Cellular and Infection Microbiology
PurposeThis study aimed to develop and validate a novel web-based calculator using machine learning algorithms to predict fragility fracture risk in People living with HIV (PLWH), who face increased morbidity and mortality from such fractures.MethodWe retrospectively analyzed clinical data from Beijing Ditan Hospital orthopedic department between 2015 ...
Bo Liu   +5 more
openaire   +3 more sources

Primary headache disorders:Five new things

open access: yes, 2019
Purpose of review: To review 5 new areas in primary headache disorders, especially migraine and cluster headache. Recent findings: Calcitonin gene-related peptide (CGRP) receptor antagonists (gepants - rimegepant and ubrogepant) and serotonin 5-HT1F ...
Goadsby, Peter J.; id_orcid
core   +1 more source

Effects of Ditan Tongmai Decoction in combination with acupuncture on post-stroke recovery based on electroencephalogram

open access: yesČeská a slovenská neurologie a neurochirurgie, 2022
Lu Zhang   +5 more
openaire   +1 more source

Receptors for the Acute Therapy of Migraine: A Literature Review

open access: yes, 2019
Objective: To review and highlight current literature on emerging acute migraine treatments, focusing on CGRP receptor antagonists, gepants, and 5-HT1F receptor agonists (ditans).
Villar-Martínez, María Dolores   +7 more
core   +1 more source

Les nouveaux traitements antimigraineux

open access: yes, 2020
La migraine est la deuxième cause d’invalidité dans le monde et la première chez les personnes âgées de moins de 50 ans. En France, 20 % de la population est touchée par ce fléau et les traitements disponibles ont une efficacité variable, parmi lesquels ...
Chung, Alexandre
core  

Results of a Web-Based Survey on 2565 Greek Migraine Patients in 2023: Demographic Data, Imposed Burden and Satisfaction to Acute and Prophylactic Treatments in the Era of New Treatment Options

open access: yes
Objective: The Greek Society of Migraine and Headache Patients conducted its third in-line population web-based survey in 2023 to ascertain if the burden of the disease and the patients’ satisfaction with conventional and novel migraine therapies ...
Konstantinos Bilias   +8 more
core   +1 more source

Home - About - Disclaimer - Privacy